|4Jan 3, 6:59 PM ET

BOYER HERBERT W PH D 4

4 · ALLERGAN INC · Filed Jan 3, 2013

Insider Transaction Report

Form 4
Period: 2013-01-02
Transactions
  • Award

    Phantom Stock Units

    2013-01-02$94.04/sh+265.84$25,00017,894.67 total
    Common Stock (265.84 underlying)
  • Award

    Phantom Stock Units

    2012-12-12$93.34/sh+9.44$88117,628.83 total
    Common Stock (9.44 underlying)
Footnotes (4)
  • [F1]Converts to common stock on a 1-for-1 basis.
  • [F2]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for quarterly dividend, exempt transaction under Rule 16a-11.
  • [F3]Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. Director.
  • [F4]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for quarterly portion of annual retainer.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT